Literature DB >> 3882343

Plasma membrane phospholipid organization in human erythrocytes.

R S Schwartz, D T Chiu, B Lubin.   

Abstract

By weight, phospholipids make up approximately 25% of the plasma membrane of mature human erythrocytes. The four major phospholipid species present in the membrane (PC, PE, PS, and SM) are distributed asymmetrically across the bilayer leaflet resulting in an enrichment of choline-phospholipid (PC and SM) in the outer leaflet and of amino-phospholipid (PE and PS) in the cytoplasmic leaflet. This asymmetric organization is preferentially maintained through complex, and at present, poorly understood noncovalent interactions between specific membrane lipids and proteins (in particular, a stabilizing role for the skeletal protein spectrin and band 4.1 have been implicated), although other considerations such as phospholipid net charge, size, and degree of acyl chain unsaturation may also be involved. In certain red cell pathologies, or following experimental manipulation, there is a partial loss of this asymmetry (summarized in Tables XVI, XVII) often resulting in increases in the outer leaflet content of amino-phospholipids and subsequent expression of altered membrane surface properties. Some of these abnormal properties may have pathophysiologic consequence; indeed, red cell membranes displaying increased levels of surface amino-phospholipids have been shown to be potent procoagulants and demonstrate enhanced intermembrane interactions with both model (liposomes) and biologic (mononuclear phagocytes) membranes. Redistribution of membrane phospholipids may not occur homogeneously throughout an entire leaflet but may be restricted to specific membrane regions. These studies strongly suggest that the maintenance of phospholipid asymmetry in human red cell membranes is not a trivial event but probably represents a homeostatic mechanism, the failure of which may lead to alterations in normal erythrocyte functions, and ultimately, survival.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882343

Source DB:  PubMed          Journal:  Curr Top Hematol        ISSN: 0190-1486


  7 in total

1.  Human erythrocyte protein 4.1 is a phosphatidylserine binding protein.

Authors:  A C Rybicki; R Heath; B Lubin; R S Schwartz
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Detection of short-chain carbonyl products of lipid peroxidation from malaria-parasite (Plasmodium vinckei)-infected red blood cells exposed to oxidative stress.

Authors:  G D Buffinton; N H Hunt; W B Cowden; I A Clark
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

3.  Resynthesis of sphingomyelin from plasma-membrane phosphatidylcholine in BHK cells treated with Staphylococcus aureus sphingomyelinase.

Authors:  D Allan; P Quinn
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

4.  Design, Spectral Characteristics, Photostability, and Possibilities for Practical Application of BODIPY FL-Labeled Thioterpenoid.

Authors:  Galina B Guseva; Elena V Antina; Mikhail B Berezin; Anastassia S Smirnova; Roman S Pavelyev; Ilmir R Gilfanov; Oksana G Shevchenko; Svetlana V Pestova; Evgeny S Izmest'ev; Svetlana A Rubtsova; Olga V Ostolopovskaya; Sergey V Efimov; Vladimir V Klochkov; Ilfat Z Rakhmatullin; Ayzira F Timerova; Ilya A Khodov; Olga A Lodochnikova; Daut R Islamov; Pavel V Dorovatovskii; Liliya E Nikitina; Sergei V Boichuk
Journal:  Bioengineering (Basel)       Date:  2022-05-12

5.  Differential gene expression during terminal erythroid differentiation.

Authors:  S Koury; S Yarlagadda; K Moskalik-Liermo; N Popli; N Kim; C Apolito; A Peterson; X Zhang; P Zu; J Tamburlin; D Bofinger
Journal:  Genomics       Date:  2007-08-31       Impact factor: 5.736

6.  Influence of diet on (n-3) and (n-6) fatty acids in monkey erythrocytes.

Authors:  M A Carman; J L Beare-Rogers
Journal:  Lipids       Date:  1988-05       Impact factor: 1.880

7.  The biochemical modification of the erythrocyte membranes from women with ovarian cancer.

Authors:  Z Kopczyński; J Kuźniak; A Thielemann; J Kaczmarek; M Rybczyńska
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.